CJL
LLY icon

Cyrus J. Lawrence’s Eli Lilly LLY Stock Holding History

Cyrus J. Lawrence’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$1.09M Sell
1,320
-22,201
-94% -$18.5M 4.13% 5
2024
Q4 		$18.2M Buy
23,521
+1,889
+9% +$1.56M 3.51% 8
2024
Q3 		$19.2M Buy
21,632
+381
+2% +$343K 3.76% 5
2024
Q2 		$19.2M Sell
21,251
-25
-0.1% -$20K 3.9% 5
2024
Q1 		$16.6M Buy
+21,276
New +$15.1M 3.67% 5
2023
Q3 		$11.6M Buy
21,653
+238
+1% +$123K 3.19% 6
2023
Q2 		$10M Sell
21,415
-50
-0.2% -$21K 2.17% 8
2023
Q1 		$7.37M Sell
21,465
-393
-2% -$133K 2.14% 22
2022
Q4 		$8M Sell
21,858
-79
-0.4% -$28K 2.39% 16
2022
Q3 		$7.09M Buy
21,937
+20,313
+1,251% +$6.44M 1.39% 22
2022
Q2 		$527K Hold
1,624
– – 0.15% 60
2022
Q1 		$465K Buy
+1,624
New +$418K 0.11% 66

Other funds holding LLY

PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Cyrus J. Lawrence's LLY Position: Q1 2025 in Review

Cyrus J. Lawrence reduced its Eli Lilly (LLY) stake by 94% in Q1 2025, selling an estimated $18.5M and leaving 1,320 shares worth $1.09M. The position accounts for 4.13% of the portfolio, ranked #5.

Cyrus J. Lawrence first reported a position in LLY in Q1 2022 and has held it in 12 quarters since. The position peaked at $19.2M in Q2 2024. 3,927 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • Cyrus J. Lawrence held 1,320 shares of Eli Lilly worth $1.09M as of Q1 2025.
  • Cyrus J. Lawrence sold 22,201 Eli Lilly shares in Q1 2025, an estimated $18.5M.
  • Eli Lilly made up 4.13% of Cyrus J. Lawrence's portfolio in Q1 2025, its #5 holding.
  • Cyrus J. Lawrence first reported a position in Eli Lilly in Q1 2022 and has held it in 12 quarters since.
  • Cyrus J. Lawrence's Eli Lilly position peaked at $19.2M in Q2 2024.
  • 3,927 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on Cyrus J. Lawrence's 13F filing for Q1 2025, filed 15 May 2025.